Earth Science Tech, Inc. President Commits to Donating 50,000 of his Personal Shares to Become the First Contributor to Earth Science Foundation

Doral, FL, Jan. 18, 2018 (GLOBE NEWSWIRE) --

Earth Science Tech, Inc. (OTC PINK: ETST) (“ETST" or the “Company"), an innovative biotech company that operates in the fields of cannabinoid (CBD), nutraceutical and pharmaceutical and is focused on R&D for certain medical devices, announced today that Company President Nickolas S. Tabraue has committed to donating 50,000 of his personal shares to become the first contributor to Earth Science Foundation (the ”Foundation”). The Foundation has been formed to help individuals who are in need of the products the Company manufactures as well as future formulas that are being developed by the Company in order to meet their health needs.

The Foundation which was discussed in a press release earlier this month is the Company’s  nonprofit entity, designed to assist patients who need assistance with obtaining products produced by the Company  in order to meet their medical needs. The company is currently in the process of qualifying as a 501 (c)(3) organization and becoming structured with key individuals to help those in need, the Company is currently in discussions with medical practitioners, organizations and schools to secure donations  for ETST’s popular and effective cannabinoid products.

The Foundation’s goal is to help individuals suffering from cancer, epilepsy, autism, addiction and chronic pain who are not able to afford ETST’s products assisting them in obtaining these products at a reasonable price or at no cost. ETST plans to include participating organizations and those taking part in human trials and to provide them with  the benefits and supplies at our cost following the conclusion of these studies. To help fund this effort, Earth Science Foundation will accept donations on its GoFundMe Page

Gabriel Aviles, ETST’s chief sales officer, who will soon be named as the Company’s chief learning officer, will help educate the participating organizations regarding the benefits of cannabinoids and will further provide education on the studies he plans to conduct. The Company is finalizing preparations to launch its anti-opioid cannabinoid formula and is ready to study its cannabinoid formula on autism symptoms, given the significant positive feedback the Company has received from individuals diagnosed with autism.

Mr. Aviles comments, “We are at the forefront of a new frontier in modern medicine. We have seen the tremendous potential our formulas have to improve the health of our patients, and we want to formally research and share our results and our life-changing treatments with as many people as we can, Our ability to do this stems from the education we provide. I will do my best to educate students, teachers, parents and the medical community on the benefits we have discovered in CBD-based treatments.”

Mr. Tabraue, the Company’s president, director and COO, has agreed to donate the shares of compensation he is to receive for Q1 2018, equal to  50,000 shares, to the Foundation. The shares will be used as an asset for the Foundation as it continues to grow and requires additional funds to help meet its obligations.

Mr. Tabraue concludes, “I have received a tremendous amount of positive feedback regarding our CBD-based products from children, adults and elderly patients alike who are suffering from cancer, epilepsy, chronic pain and autism, just to name a few. Nothing feels better than knowing my Company’s products have helped change peoples’ lives in a positive way. I do know there are many patients who are not able to purchase our products and they seek extra help in addition to the discounts we offer. Through the Foundation, I feel we can truly help those in need continue to find improved health.. As mentioned earlier, I am currently in talks with many great medical practitioners, schools and organizations, and I plan on sharing updates as they progress.”

About Earth Science Tech, Inc. (ETST): Earth Science Tech has among the highest quality, purity, and full spectrum High Grade Hemp CBD (Cannabidiol) Oil on the market. Made using the superior supercritical CO2 liquid extraction, our CBD Oil is 100% natural and organic. Our research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrate that we are the top nutritional and dietary supplement brand for High Grade Hemp CBD Oil.

To learn more and to buy CBD Hemp Oil, please visit:

About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (Sexually Transmitted Infections and/or Diseases). Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit:

About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics, Inc. was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals as well as other products & solutions. Cannabis Therapeutics mission it to help change the healthcare landscape by introducing their proprietary cannabis-cannabinoid based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit:

About KannaBidioiD: KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioid, Inc. is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by its unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit:

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.


Contact Data